| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1015373795 |
| P356 | DOI | 10.1038/ONC.2010.300 |
| P8608 | Fatcat ID | release_46jkvien4jgrzazdxcfvhbs2xi |
| P953 | full work available at URL | https://europepmc.org/articles/pmc2967730?pdf=render |
| https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20676140/?tool=EBI | ||
| https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20676140/pdf/?tool=EBI | ||
| https://europepmc.org/articles/PMC2967730 | ||
| https://europepmc.org/articles/PMC2967730?pdf=render | ||
| https://www.nature.com/articles/onc2010300.pdf | ||
| https://www.nature.com/articles/onc2010300 | ||
| P932 | PMC publication ID | 2967730 |
| P698 | PubMed publication ID | 20676140 |
| P5875 | ResearchGate publication ID | 45440993 |
| P2093 | author name string | W. Wang | |
| L. Cheng | |||
| Z. Zhou | |||
| J. Camps | |||
| A. Y. Nikitin | |||
| T. Ried | |||
| A. Flesken-Nikitin | |||
| I. A. Toshkov | |||
| P2860 | cites work | pRb inactivation in mammary cells reveals common mechanisms for tumor initiation and progression in divergent epithelia | Q21090243 |
| Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach | Q24633776 | ||
| Expression of Yes-associated protein in common solid tumors | Q24657592 | ||
| Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon | Q24682018 | ||
| Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | Q27860709 | ||
| Repeated observation of breast tumor subtypes in independent gene expression data sets | Q28131820 | ||
| Fate of the mammalian cardiac neural crest | Q28139176 | ||
| Principles of tumor suppression | Q28240740 | ||
| Cancer statistics, 2009 | Q29547625 | ||
| Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours | Q29547697 | ||
| Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis | Q29616631 | ||
| Tumor spectrum analysis in p53-mutant mice | Q29617436 | ||
| Transcriptional control of human p53-regulated genes | Q29617650 | ||
| The molecular portraits of breast tumors are conserved across microarray platforms | Q33241398 | ||
| The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting | Q33860801 | ||
| WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis | Q33860814 | ||
| RB has a critical role in mediating the in vivo checkpoint response, mitigating secondary DNA damage and suppressing liver tumorigenesis initiated by aflatoxin B1 | Q34298366 | ||
| Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice | Q34342812 | ||
| Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer | Q34374852 | ||
| Cyclin D1 and breast cancer | Q34567256 | ||
| The RB and p53 pathways in cancer | Q34804764 | ||
| MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression | Q34960600 | ||
| TP53 and breast cancer | Q35078761 | ||
| High frequency of aberrant p16(INK4A) expression in human breast cancer | Q35782316 | ||
| Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome | Q35829654 | ||
| Role of raloxifene in breast cancer prevention in postmenopausal women: clinical evidence and potential mechanisms of action | Q35840621 | ||
| Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer | Q35901185 | ||
| RB family members as predictive and prognostic factors in human cancer | Q36579289 | ||
| Role of the retinoblastoma tumor suppressor in the maintenance of genome integrity | Q36651860 | ||
| RB in breast cancer: at the crossroads of tumorigenesis and treatment | Q36760000 | ||
| Cellular mechanisms of tumour suppression by the retinoblastoma gene. | Q37225340 | ||
| Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers | Q37272977 | ||
| IAP-targeted therapies for cancer | Q37302745 | ||
| Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo | Q37346696 | ||
| Tumour suppression by p53: a role for the DNA damage response? | Q37591937 | ||
| Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation | Q40368518 | ||
| Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum | Q40442891 | ||
| Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. | Q40526270 | ||
| Germline p53 mutations and heritable cancer | Q40614036 | ||
| Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis | Q46557073 | ||
| Mice expressing a mammary gland-specific R270H mutation in the p53 tumor suppressor gene mimic human breast cancer development. | Q46706112 | ||
| Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. | Q52544495 | ||
| Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. | Q53378102 | ||
| RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis. | Q53528048 | ||
| Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. | Q53588886 | ||
| Comparative Oncogenomics Identifies NEDD9 as a Melanoma Metastasis Gene | Q57274900 | ||
| Liver-specific pRB loss results in ectopic cell cycle entry and aberrant ploidy | Q64378607 | ||
| Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene | Q77158823 | ||
| Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer | Q80121826 | ||
| Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts | Q80441313 | ||
| P433 | issue | 42 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5700-5711 | |
| P577 | publication date | 2010-08-02 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency | |
| P478 | volume | 29 |
| Q90070043 | Anti-apoptotic factor Birc3 is up-regulated by ELL2 knockdown and stimulates proliferation in LNCaP cells |
| Q51702011 | BIRC3 single nucleotide polymorphism associate with asthma susceptibility and the abundance of eosinophils and neutrophils. |
| Q38514410 | Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway |
| Q34485060 | Cooperativity of Rb, Brca1, and p53 in malignant breast cancer evolution |
| Q47445570 | From cancer genomes to oncogenic drivers, tumour dependencies and therapeutic targets |
| Q35682449 | Genomic instability influences the transcriptome and proteome in endometrial cancer subtypes |
| Q37209606 | IAP proteins as targets for drug development in oncology |
| Q36056530 | Implanted adipose progenitor cells as physicochemical regulators of breast cancer. |
| Q37651843 | Induced p53 loss in mouse luminal cells causes clonal expansion and development of mammary tumours. |
| Q90828113 | Integrative analysis of copy number and gene expression data identifies potential oncogenic drivers that promote mammary tumor recurrence |
| Q46082295 | Iron overload signature in chrysotile-induced malignant mesothelioma |
| Q38794695 | MicroRNA-34a promotes genomic instability by a broad suppression of genome maintenance mechanisms downstream of the oncogene KSHV-vGPCR. |
| Q90163150 | Moderate Exercise Modulates Tumor Metabolism of Triple-Negative Breast Cancer |
| Q41892098 | Organ size control is dominant over Rb family inactivation to restrict proliferation in vivo |
| Q37395680 | RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation |
| Q26766039 | Report on the use of non-clinical studies in the regulatory evaluation of oncology drugs |
| Q47100005 | Risk Factors and Preventions of Breast Cancer |
| Q42363612 | The Chromatin Remodeling Component Arid1a Is a Suppressor of Spontaneous Mammary Tumors in Mice |
| Q37512362 | The Inhibitor of Apoptosis (IAPs) in Adaptive Response to Cellular Stress |
| Q47850800 | p53 shades of Hippo. |
Search more.